Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 2
1975 1
1976 3
1978 2
1979 1
1981 1
1983 1
1984 1
1985 1
1986 1
1988 1
1991 1
2003 1
2009 1
2011 1
2012 6
2013 4
2014 4
2015 5
2016 5
2017 7
2018 4
2019 3
2020 7
2021 8
2022 10
2023 8
2024 14
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

112 results

Results by year

Filters applied: . Clear all
Page 1
Mortality after surgery in Europe: a 7 day cohort study.
Pearse RM, Moreno RP, Bauer P, Pelosi P, Metnitz P, Spies C, Vallet B, Vincent JL, Hoeft A, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Pearse RM, et al. Lancet. 2012 Sep 22;380(9847):1059-65. doi: 10.1016/S0140-6736(12)61148-9. Lancet. 2012. PMID: 22998715 Free PMC article.
TFEB controls sensitivity to chemotherapy and immuno-killing in non-small cell lung cancer.
Akman M, Monteleone C, Doronzo G, Godel M, Napoli F, Merlini A, Campani V, Nele V, Balmas E, Chontorotzea T, Fontana S, Digiovanni S, Barbu FA, Astanina E, Jafari N, Salaroglio IC, Kopecka J, De Rosa G, Mohr T, Bertero A, Righi L, Novello S, Scagliotti GV, Bussolino F, Riganti C. Akman M, et al. Among authors: merlini a. J Exp Clin Cancer Res. 2024 Aug 7;43(1):219. doi: 10.1186/s13046-024-03142-4. J Exp Clin Cancer Res. 2024. PMID: 39107857 Free PMC article.
Ecteinascidin synthetic analogues: a new class of selective inhibitors of transcription, exerting immunogenic cell death in refractory malignant pleural mesothelioma.
Salaroglio IC, Aviles P, Kopecka J, Merlini A, Napoli F, Righi L, Novello S, Sullivan H, Cuevas C, Scagliotti GV, Riganti C. Salaroglio IC, et al. Among authors: merlini a. J Exp Clin Cancer Res. 2024 Dec 21;43(1):327. doi: 10.1186/s13046-024-03253-y. J Exp Clin Cancer Res. 2024. PMID: 39709435 Free PMC article.
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
Galvagno F, Leuci V, Massa A, Donini C, Rotolo R, Capellero S, Proment A, Vitali L, Lombardi AM, Tuninetti V, D'Ambrosio L, Merlini A, Vigna E, Valabrega G, Primo L, Puliafito A, Sangiolo D. Galvagno F, et al. Among authors: merlini a. Cancer Immunol Immunother. 2024 Nov 2;74(1):6. doi: 10.1007/s00262-024-03860-w. Cancer Immunol Immunother. 2024. PMID: 39487859 Free PMC article.
GDF-15 Predicts Epithelioid Hemangioendothelioma Aggressiveness and Is Downregulated by Sirolimus through ATF4/ATF5 Suppression.
Stacchiotti S, Martini S, Pasquali S, Frezza AM, Beretta A, Percio S, Lecchi M, Tortoreto M, Barisella M, Collini P, Dagrada GP, Merlini A, Huang PH, Jenks A, Jones RL, Tap WD, Ingrosso M, Morosi C, Brich S, Giani C, Verderio P, Casali PG, Leonard H, Gronchi A, Zuco V, Zaffaroni N. Stacchiotti S, et al. Among authors: merlini a. Clin Cancer Res. 2024 Nov 15;30(22):5122-5137. doi: 10.1158/1078-0432.CCR-23-3991. Clin Cancer Res. 2024. PMID: 39283723 Free PMC article.
Extended molecular profiling in mesenchymal tumors: a consensus paper from the Italian Sarcoma Group.
D'Ambrosio L, Sbaraglia M, Merlini A, Rabino M, Grignani G, Appolloni V, Badalamenti G, Baldi GG, Bellan E, Benelli M, Bertuzzi AF, Biagini R, Bianchi G, Boglione A, Brunello A, Campanacci DA, Cananzi F, Casali PG, Casini B, Cesari M, Chiusole B, Cristalli C, De Vita A, Di Blasi E, Fagioli F, Fausti V, Ferraresi V, Frezza AM, Fumagalli E, Gambarotti M, Giani C, Gronchi A, Grassi M, Ibrahim T, Ivanescu A, Ignazzi G, Incorvaia L, Linari A, Luksch R, Marrari A, Mazzocca A, Milano GM, Morosi C, Nannini M, Navarria P, Palassini E, Palmerini E, Paloschi F, Pantaleo MA, Pasquali S, Pavese V, Pozzo E, Quagliuolo V, Quirino M, Sanfilippo R, Santoro F, Scotlandi K, Serra M, Setola E, Strippoli S, Tafuto S, Tirtei E, Vanni S, Vincenzi B, Maestro R, Dei Tos AP, Stacchiotti S. D'Ambrosio L, et al. Among authors: merlini a. Crit Rev Oncol Hematol. 2025 Dec;216:104960. doi: 10.1016/j.critrevonc.2025.104960. Epub 2025 Sep 23. Crit Rev Oncol Hematol. 2025. PMID: 40998028 Free article. Review.
A prospective study on clinicians' attitudes and survival outcomes for patients with advanced NSCLC and poor performance status in the immunotherapy era: PICASO (GOIRC-04-2020).
Facchinetti F, Camerini A, Bennati C, Bordi P, De Carlo E, Mazzoni F, Metro G, Bertolini F, Longo L, Ricciardi S, Pilotto S, Giardina D, Passiglia F, Scotti V, Piacentini P, Frega S, Calabrò L, Guida A, Grosso MA, Longobardi J, Merlini A, Cosso F, Leonetti A, Gariazzo E, Guaitoli G, Belluomini L, Bearz A, Tognetto M, Bria E, Cortinovis DL, Novello S, Maio MD, Tiseo M. Facchinetti F, et al. Among authors: merlini a. Lung Cancer. 2025 Jun;204:108580. doi: 10.1016/j.lungcan.2025.108580. Epub 2025 May 17. Lung Cancer. 2025. PMID: 40382877
112 results